Executive Assistant to the CEO
Kris Schindel has a remarkable depth of IHE-related knowledge, having held her position since 1996, shortly after the Institute was formed.
In September 2013, the IHE in support of the Government of Alberta will be holding two major conferences on the topic of Fetal Alcohol Spectrum Disorder (FASD): the First International Conference on Prevention of FASD (September 23-25, 2013) and a Consensus Development Conference on Legal Issues of FASD (September 18-20, 2013).
This health technology assessment report has been produced in response to a request from Alberta Health (AH) as part of the Alberta Health Technologies Decision Process (AHTDP) to perform an evaluation of the scientific evidence on the safety and effectiveness of TMJ Concepts® and Biomet® Microfixation TMJ prostheses for adults who are indicated for total TMJ replacement.
The objectives for the economic analysis are to determine the cost effectiveness of total TMJ replacement surgery compared to no surgical intervention and to determine the budget impact of total TMJ replacement.
This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late pre-term neonates. This report also provides information regarding the current practices with TcB/total serum bilirubin (TSB) tests in AHS zones, and a brief review of economic literature regarding the cost implications and potential cost-effectiveness of TcB and/or TSB testing.
The review summarizes the current evidence on the safety, efficacy, effectiveness, and potential cost-effectiveness on the use of the BridgePoint Medical System (consisting of the CrossBossTM catheter, StingrayTM catheter, and StingrayTM guidewire) for the recanalization of refractory coronary chronic total occlusions (CTOs). The report also describes the relevant outcomes for studies of percutaneous coronary intervention (PCI) for coronary CTOs.